Clinical Trials Browser

Terminated × Melanoma × Monatide (IMS 3015) × Clear all

NCT01810016 2022-10-12

NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma

Phase 1 Terminated

8 enrolled 16 charts

Melanoma, Neoplasms

NCT01308294 2020-06-11

LAG-3/IMP321

Phase 1/2 Terminated

16 enrolled 12 charts

Melanoma